Marksans Pharma Limited (NSE:MARKSANS)
233.50
-5.64 (-2.36%)
Jun 5, 2026, 3:30 PM IST
Marksans Pharma Employees
Marksans Pharma had 1,840 employees as of March 31, 2025. The number of employees increased by 699 or 61.26% compared to the previous year.
Employees
1,840
Change (1Y)
699
Growth (1Y)
61.26%
Revenue / Employee
16.04M INR
Profits / Employee
2.27M INR
Market Cap
105.67B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 1,840 | 699 | 61.26% |
| Mar 31, 2024 | 1,141 | 289 | 33.92% |
| Mar 31, 2023 | 852 | -38 | -4.27% |
| Mar 31, 2022 | 890 | -248 | -21.79% |
| Mar 31, 2021 | 1,138 | -12 | -1.04% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Apollo Hospitals Enterprise | 42,497 |
| Cipla | 30,313 |
| MedPlus Health Services | 25,007 |
| Divi's Laboratories | 10,542 |
| HealthCare Global Enterprises | 6,736 |
| Park Medi World | 5,911 |
| Metropolis Healthcare | 4,823 |
Marksans Pharma News
- 5 days ago - Marksans Pharma launches 'Saksham Niveshak' campaign to address unclaimed dividends - Business Upturn
- 6 days ago - Marksans Pharma to acquire Netherlands-based QliniQ B.V. to expand presence in European markets - Business Upturn
- 11 days ago - Marksans Pharma Transcript: Q4 25/26 - Transcripts
- 11 days ago - Marksans Pharma Quarterly report: Q4 2026 - Filings
- 11 days ago - Marksans Pharma Slides: Q4 2026 - Filings
- 12 days ago - Marksans Pharma reports highest-ever revenue of Rs 3,033 crore for FY26 - Business Upturn
- 12 days ago - Marksans Pharma Q4 Results: Net profit jumps 64% as EBITDA margin expands sharply - Business Upturn
- 2 months ago - Marksans Pharma receives USFDA approval for Benzonatate Capsules - Business Upturn